Peptide record

TPDB91453

R9-PCP Antibacterial Antifungal Antiviral Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91453
R9-PCP
Antibacterial Antifungal Antiviral Blood-Brain Barrier Cell-penetrating Peptides
Anti-infective peptides Delivery and barrier-penetrating peptides
AntiBP3 Peptipedia CAFPdb dbAMP CellPPD CellPPD-MOD CPPsite3.0 PerseuCPP
modified_plain
Yes
A 9-aa modified multi-activity (Antibacterial, Antifungal, Antiviral, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
C-terminal: Amidation Chemical: Φ, L-2-naphthylalanine,miniPEG, 8-amino-3,6-dioxaoctanoic acid N-terminal: Acetylation
Sequence
Ac-RRRRRRRRR-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
Amidation Activity
Φ, L-2-naphthylalanine,miniPEG, 8-amino-3,6-dioxaoctanoic acid Activity
L Activity
Cationic Activity
Linear Activity
Acetylation Activity
N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

HEK293, HeLa, MCF-7, NIH 3T3, A549, Jurkat, H1650, and H1299 cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Synthetic
Peptide [PCP, miniPEG-DE(pCAP)LI-NH2]
Cytoplasm and nucleus
Lower efficiency
Endocytic pathway
In vitro
CCCCCCCCC
Additional Detail Fields 1 fields
CCCCCCCCC